Topical treatment of venereal warts: A comparative open study of podophyllotoxin cream versus solution

被引:40
作者
Claesson, U [1 ]
Lassus, A [1 ]
Happonen, H [1 ]
Hogstrom, L [1 ]
Siboulet, A [1 ]
机构
[1] VASASTADENS LAKARMOTTGN,SKOVDE,SWEDEN
关键词
condylomata acuminata; topical treatment; podophyllotoxin;
D O I
10.1258/0956462961918400
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Podophyllotoxin solution (0.5%) is licensed for use in the treatment of condylomata acuminata (genital warts) in men in a number of European countries. In some countries, approval also extends to treatment of genital warts in women. This controlled randomized prospective study evaluated the efficacy and safety of a cream formulation of podophyllotoxin at 2 concentrations (0.15% and 0.3%), using 0.5% podophyllotoxin solution as a reference treatment. Two separate studies were initiated, to assess the 3 treatment groups in (a) male patients, and (b) female patients. Statistical evaluation was based on a 'response rate' calculated at each clinic visit. The mean 'response rates' in the male patient study at 4 weeks were 75.1%, 79.0% and 85.6% in the 0.15% cream, 0.3% cream and 0.5% solution groups, respectively. The corresponding 'response rates' for the female patient study were 86.2%, 92.6%, and 93.1%, respectively. The relapse rates for both male and female patients were 6.0% in the 0.15% cream group, 8.6% in the 0.3% cream group and 8.6% in the 0.5% solution group. The results show that there were no statistically significant differences between the 3 treatments with regard to both efficacy and safety. This was true for both the male and female patient groups.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 23 条
[2]  
BARASSO R, 1987, NEW ENGL J MED, V317, P916
[3]   PATIENT-APPLIED PODOFILOX FOR TREATMENT OF GENITAL WARTS [J].
BEUTNER, KR ;
FRIEDMANKIEN, AF ;
ARTMAN, NN ;
KING, DH ;
CONANT, MA ;
ILLEMAN, M ;
THISTED, RA .
LANCET, 1989, 1 (8642) :831-834
[4]  
Chow V T, 1991, Int J STD AIDS, V2, P41
[5]  
*DEP HLTH SOC SEC, 1984, BR J VENER DIS, V60, P199
[6]  
DUUS BR, 1985, GENITOURIN MED, V61, P59
[7]  
EDWARDS A, 1988, GENITOURIN MED, V64, P263
[8]  
ENDRES JC, 1994, SURG CLIN N AM, V74, P1415
[9]   PREVENTING CERVICAL-CANCER BY TREATING GENITAL WARTS IN MEN - WHY MALE SEX PARTNERS NEED ANDROSCOPY [J].
EPPERSON, WJ .
POSTGRADUATE MEDICINE, 1990, 88 (05) :229-&
[10]  
GREENBERG MD, 1991, OBSTET GYNECOL, V77, P735